As the global gastrointestinal test panel market grows, so does the number of companies that have the opportunity to monetize their knowledge of gastrointestinal tract health. If you’re looking for an IG panel yourself or just want to hear about some influential startups, check out these leading companies. These are a few companies you might want to keep close to your heart during the 2020 review.

What is the Gastrointestinal Testing Panels Market?

To examine the gastrointestinal testing panel market, it is important to understand what is used for testing and how it affects different animals. Hayes-May estimated that the global gastrointestinal specimen testing market in 2022 will be worth $8.82 billion, with strong growth expected over the next few years due to increased technological innovation.

Click on the tab below to avail the sample copy of the report [email protected]

Sample request

Leading companies in the gastrointestinal testing panel market

Over the past decade, gut health and metabolic disorders have been among the most important areas for US pharmaceutical companies. Major market players like Roche (OTCQX: RHHBY), Genzyme (Neogen, Neurim Pharmaceuticals), Mosby CapRock Biotherapeutics, GE Healthcare (UHealth), Incis Care (DMAS), Merck KGaA, Organon
(Organa Labs) are focusing on new therapies to treat these new disorders.

Technological innovations

The market has changed tremendously over the past few years, with increasing technological advancements. It is therefore crucial for companies to try to stay at the forefront of the market, which a large number of companies that have entered this field have failed to do. With so many companies entering this market, it’s easy to see why the demand for additional information is becoming more and more prevalent.

Click on the tab below for the instant purchase of the report with a flat rate discount of $500

Instant Buy Request

Conclusion

The gastrointestinal and metabolic testing panel market is expected to reach USD 3.66 billion by 2023, growing at a CAGR of 5.03% from 2017 to 2023.